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Abstract
The molecular age histopathologist of today is practicing pathology in a totally different scenario
than the preceding generations did. Histopathologists stand, as of now, on the cross roads of a
traditional 'visible' morphological science and an 'invisible' molecular science. As molecular
diagnosis finds more and more applicability in histopathological diagnosis, it is time for the policy
makers to reframe the process of accreditation and re-accreditation of the modern
histopathologist in context to the rapid changes taking place in this science. Incorporation of such
'molecular' training viv-a-vis information communication technology skills viz. telemedicine and
telepathology, digital imaging techniques and photography and a sound knowledge of the economy
that the fresh entrant would ultimately become a part of would go a long way to produce the
Modern Histopathologist. This review attempts to look at some of these aspects of this rapidly
advancing 'art of science.'
Introduction
In an era when we are talking of molecular classification
of traditional histology and immunotherapy for cancers,
the role of the histo-morphologist seems to be exploring
areas which one could never have imagined a few decades
ago. With the rapidly advancing field of biotechnology
and molecular biology, a modern histopathologist is
expected to be well versed not only in the traditional his-
topathological techniques but also keep pace with the
ever expanding frontiers of science and technology. With
molecular diagnosis threatening to overrule the his-
topathological diagnosis with every new discovery, it is
time for the histopathologist to embrace and incorporate
the recent advancements of practicing pathology in its
present modern context.
With the fast changing scenario, it is but obvious that the
accreditation of the histopathologist needs to undergo a
drastic change, and re-accreditation of those already in the
field a necessity. The current accreditation process preva-
lent across most of the countries is to train a student with
varying degrees of vigorousity and at the end of the train-
ing period, assess the candidate through an examination
which gives the license to practice pathology throughout
life. In this scenario, it is totally up to the pathologist's
own efforts and interest to keep up all the enthusiasm of
keeping abreast with the newer technologies and new
diagnostic trends. Whereas primary accreditation looks at
what the new practitioner can do, re-accreditation looks at
what established practitioners actually do. The accredita-
tion and re-accreditation procedure hence needs to incor-
porate not only the traditional histopathological
techniques but also the fields of biotechnology, telecom-
munication, information communication technology,
professional photography and a bit economics. To this list
could be added a number of other entities such as socio-
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psychological factors, hospital management, quality con-
trol and host of others which is beyond the scope of this
discussion. The subject of accreditation and re-accredita-
tion however has been a topic of constant reviews where
authors have tried to devise list of areas where a his-
topathologist should be able to demonstrate continuing
fitness to practice, and activities like recording educa-
tional activity, testing a pathologist's knowledge and
interpretative skills, testing his diligence and peer review/
appraisal has been proposed as various ways and tools to
assess a practicing pathologist [1].
Discussion
There was a time when Pathology was considered to be
the mother of medical science. Histopathology, over the
years has witnessed its evolution from a mainly autopsy
based pathology to the current molecular histopathology.
Recent advances in various fields of science and technol-
ogy and the incorporation of these to histopathological
practice and acceptance of some philosophical concepts,
particularly the functional correlation of morphological
studies, has changed the outlook of both histopathology
and the histopathologist. An elaborate review on the topic
at the turn of the century by Mapstone and Quirke [2] on
the pathologist in context to the 21st century reveals that
the ideas and concepts that were envisioned then, has to a
large extent, already found widespread acceptance in the
pathology community, if not moved further into it. This is
particularly true for the application of information tech-
nology, and to a lesser extent to molecular biology
advances.
It's been sometime now since the human genome has
been sequenced. The initial enthusiasm of reading the
blueprint of human biology however seems nowhere in
sight and it is likely to be a number of decades before
many of the expected benefits of the genomics revolution
are actually realized to the extent initially expected. The
human genome project seems to have opened the Pan-
dora's Genomic Box resulting in more questions than
answers.
The first and most widespread application of molecular
techniques in histopathology perhaps came in the form of
immunohistochemistry (IHC), though IHC perhaps can-
not be called a molecular technique in its true sense.
Albert H. Coons and his colleagues were the first to use
fluorescent dye labeled antibodies to identify antigens in
tissue sections. Subsequently, enzyme labels such as per-
oxidase (Nakane and Pierce 1966), alkaline phosphatase
(Mason and Sammons 1978) and Colloidal gold (Faulk
and Taylor 1971) were introduced. Within a short time,
histopathology literature was flooded with immunohisto-
chemistry-based studies, expanding both the list of mark-
ers as well as the list of confusion. A pubmed search as on
31st March 2008 for "immunohistochemistry" yielded a
total of 415067 papers with 12,426 reviews reflecting the
impact immunohistochemistry have had on the scientific
community. The impact of the scientific breakthroughs
has however started becoming more apparent gradually.
This can be said more confidently when we talk of the
contribution of the gene array technology, which allows
gene expression measurements of thousands of genes in
parallel, providing a powerful tool for pathologists seek-
ing new markers for diagnosis. With such kind of data
accumulating rapidly, it won't be long when molecular
signatures would be assigned to each and every patholog-
ical lesion and a molecular diagnosis would come even
before the paraffin sections are ready, and the his-
topathologist would already know what to look for in the
sections.
Various studies have demonstrated that micro-array based
gene expression profiling enables accurate tumor classifi-
cation and can be very helpful diagnostic tool for cancers
with unknown primaries and histologically undifferenti-
ated tumors [3,4]. Molecular profiling has also given way
to the histo-clinical classifications [5-7] since such a clas-
sification would be expected to corroborate more accu-
rately with the functional behavior of a tumor. Molecular
classification systems have been attempted extensively in
organ systems like the breast and the kidney and to a
lesser extent in lungs, thyroid, endometrium, ovarian, tes-
ticular, and sarcomas. Molecular classification systems in
breast carcinoma and renal cell carcinoma have been
shown to be of relevance in not only classification and
diagnosis but also in assessing response to therapy, and as
a predictor of survival [8,9]. Whereas genomic studies are
establishing new molecular classifications, genetic altera-
tions are also being identified and characterized, generat-
ing new targets for therapy and new tools to predict
disease recurrence and response to therapy. This com-
bined molecular approach is expected to have an impact
on individual 'tailored' therapy for cancer patients.
However, with the concept of "tumor heterogeneity"
being increasingly recognized, it has become imperative
to define and analyze pure population of cells separately
within the neoplasm before assigning a molecular signa-
ture to a particular neoplasm. The advent of Laser capture
microdissection (LCM) technique has brought about this
reliable procurement of pure population of cells from tis-
sue sections under direct microscopic visualization and
bridged a very significant technical gap between the his-
topathologist's microscope and the molecular biologist's
work bench. This has now opened the doors to enhancing
our understanding of molecular mechanisms regulating
cellular developments and its functioning both in normal
and diseased states.Diagnostic Pathology 2008, 3:25 http://www.diagnosticpathology.org/content/3/1/25
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Whereas techniques like immunohistochemistry are rela-
tively simple and can be performed by the technical staff,
more sophisticated techniques involving handling of cell
culture for LCM and other molecular methods require a
more intricate knowledge on the part of the pathologist
for meaningful interpretation. It is thus important that a
student is given hands-on experience on performing these
techniques, designing of such experiments and more
importantly interpreting the data, during the initial train-
ing.
The initial excitement surrounding the development of
DNA micro array analysis and proteomics has also raised
questions about the role of these techniques in actual clin-
ical practice and patient management [10]. Though it is
theoretically possible to build a comprehensive gene
expression database for each of the organ systems/tumor
type and use it as a clinical diagnostic and prognostic tool,
microarray technology remains complex and time con-
suming and hence till date remains largely a research tool.
It is prudent thus that the histopathologist takes this
molecular approach with all his background knowledge
of morphology rather than leave tumor diagnosis entirely
in the hands of the molecular biologist to have a better
and long lasting impact.
Nature however has never been too kind to the scientist.
The story does not end with mere expression or non-
expression of a gene and production of the corresponding
mRNA. What matters at the end is the functionality of the
end product which is the 'functional' protein. The story
only begins with the production of the mRNA and the
probability of the mRNA ultimately landing up in a func-
tional protein would depend on the smooth co-ordina-
tion of an even more complicated array of biological
functions like splicing, post-translational modifications,
DNA methylation, acetylation and a host of other epige-
netic factors. What needs to be assayed is therefore the
functional aspect of the gene and the focus hence shifts
from genomics to proteomics and more recently to gly-
comics. The latter, scientists believe, will have an equally
dramatic effect as genomics have had. Given that a single
protein can come with 10 or more different forms of sug-
ars attached to it, giving the protein subtle differences in
function, which cannot be detected by the current tech-
niques in proteomics, leaves us with the possibility of
modulating the function of the protein by modulating the
activity of the enzymes that make the sugars on the pro-
tein. With the advent of the "glyco-chip" it is now possible
that histopathologists too will be hunting for the sugars
on these proteins and possibly do "Immuno-glyco-histo-
chemistry" to look at the functional aspect of the protein
they currently detect with immunohistochemistry. The
scope is ever expanding and unlimited.
Information Communication Technology (ICT) and the 
histopathologist
Working in isolated environments where access to peers,
education and information is limited, is one of the highest
risk factors for physicians' loss of medical competence
[11]. This can't be less true for the histopathologist as well.
So it's evident that for keeping pace with all the advances
taking place at an outstanding pace, dissemination of
information becomes a major issue. It is not surprising
therefore that medical science has found its place in the
electronic media or vice versa. It is also not surprising that
most if not all prominent journals in life sciences are
available on-line, though with a price tag and majority of
them has options for online-submission and peer review.
Information Communication Technology has also paved
way for telemedicine and a science which, a few years back
was a mere concept is rapidly gaining recognition as a well
defined, accepted and effective application and is already
showing its impact in clinical practice and modern health-
care. While telemedicine is a wider concept, Telepathol-
ogy is the sub-discipline of telemedicine that deals with
the capture, transmission, and viewing of pathological
and histological images via telecommunication channels
such as the internet, dedicated satellite or telephone, as
opposed to the conventional methods of microscopy.
Offering a host of innovative benefits and applications,
modern telepathology systems now help to deliver more
accurate remote diagnoses and are tending to replace tra-
ditional consultancy methods using light microscopy.
Telepathology over the years has undergone drastic evolu-
tion from static telepathology, which is a store-and-for-
ward concept to dynamic, real time telepathology, using
fully motorized robotic systems. A concordance rate of as
high as 99–100% has been reported between telepathol-
ogy and light microscopic diagnosis using such technolo-
gies [12,13]. What has however revolutionized
telepathology applications and has to a great extent
removed the most fundamental drawback of telepathol-
ogy, that is the limitation of the available image for diag-
nosis, is the concept of the "virtual slide."
Virtual slides are digitized images where the entire slide is
scanned at a very high resolution, acquiring the entire
image of the histopathology section at all magnifications
available on the microscope. Software driven motorized
stage helps acquire all the fields of view and digitally stitch
all the images into one single image which can be viewed
by multiple pathologists.
The novel array microscope for the first ultra-rapid virtual
slide processor (D Metrix DX-40) digital slide scanner is
an example [14]. The optics consists of a stack of three 80-
element 10 × 8-lenset array. Uniquely shaped lenses in
each of the lenslet arrays constitute a single "miniaturizedDiagnostic Pathology 2008, 3:25 http://www.diagnosticpathology.org/content/3/1/25
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microscope" constituting a set of 80 microscopes. Scan-
ning a glass slide with the array microscope produces
seamless two-dimensional image data of the entire slide
i.e. a virtual slide. Image acquisition can be as rapid as 58
secs for a 2.25 cm2 tissue section and 40 slides can be
scanned per hour. The only limitation would be the
extremely large file size of the images generated, some-
times exceeding 1.5 Gb and hence the limitation with the
bandwidth available for transmitting these images. It is
however not unachievable considering the fact that invest-
ing in such a facility with a high bandwidth capacity is a
one time effort, the fruit of which can be reaped for a long
time. So, with the advent of virtual microscopy, it may be
possible that an expert referral pathologist in the near
future will be interpreting virtual images on LCD screens
rather than glass slides. What needs to be emphasized is
incorporation of the concept right at the inception of the
pathology training with hands-on experience on these
concepts rather than giving a theoretical knowledge for
the simple reason that the factor which has till now ham-
pered the growth and wide-spread application of telepa-
thology is the mindset of the traditional pathologist,
despite scientific evidence of efficacy of the technique. A
technology can improve only when it finds its place in
routine practice, and it is only through trial and error that
a desired perfection is achieved. The situation however is
not that grim, and excellent examples of telepathology
applications have been set even in a country like India
which is fast shedding its third world image. With the
opening of the School of Telemedicine at the Sanjay Gan-
dhi Post Graduate Institute of Medical Sciences at Luc-
know, the first of its kind in the country, telepathology
promises a bright future in the times to come.
Histopathologist as a professional photographer
A morphologist's job is to play with images, be it live or
captured. Photography hence has been an integral part of
pathology practice since its inception. But chemical pho-
tography now has largely been replaced by digital photog-
raphy for obvious reasons. Digital cameras utilize charge-
coupled devices (CCD) or Complementary Metal Oxide
Semiconductor (CMOS) image sensors to measure light
energy and their circuitry to convert the measured infor-
mation into a digital signal. Digital photography has the
advantage of lower running cost, instant availability with-
out any processing, easy archiving and transmission
through the electronic media. It allows for adjusting,
enhancing, and annotating images. Moreover it allows for
post acquisition image optimization and modification to
suit one's satisfaction of image quality using softwares like
Adobe Photoshop. This however also carries the disadvan-
tage and the fear of falsification of images. But as is true
for every technological advance distraught with some
side-effects, the advantages of digital photography in his-
topathology practice far outweighs its disadvantages.
Patient care is enhanced by the transmission of digital
images to other individuals for consultation and educa-
tion, and by the inclusion of these images in patient care
documents. In research laboratories, digital cameras are
widely used to document experimental results and to
obtain experimental data.
Since pathology is a visual science, the inclusion of quality
digital images into lectures, teaching handouts and elec-
tronic documents is as essential as taking lectures. A few
institutions have gone beyond the basic application of
digital images to developing large electronic atlases, ani-
mated, audio-enhanced learning experiences, multidisci-
plinary internet conferences, and other innovative
applications. So isn't it wise for a postgraduate student to
handle a short course on photography at the beginning of
the training as a pathologist?
Histopathologist and the Economy
The Indian Healthcare sector, estimated to be US$ 30 bil-
lion has been growing at a frenetic pace in the past few
years. Revenues from the healthcare sector account for 5.2
per cent of the GDP and currently it employs over 4 mil-
lion people. Private spending accounts for almost 80 per
cent of total healthcare expenditure. The burgeoning
healthcare market and recent government initiatives [15]
accompanied by the socio-economic changes in the pop-
ulation has made the Indian healthcare industry an attrac-
tive investment proposition.
The private sector already accounts for about 70% of
India's health care services market and this private health-
care will continue to be the largest component in 2012
and is likely to double to US$ 35.7 billion [16]. The
chances thus of a newly qualified pathologist of landing
up in the private sector and contributing to its growth is
perhaps as high as, if not more, than the chances of being
in the public sector.
The Histopathology Market
The series of technologies developed over the years to
address the challenges of molecular diagnostics include
eight major areas: amplification technologies (gene and
signal), micro array technologies, blotting technologies,
electrophoretic technologies, probe technologies, restric-
tion fragment-length polymorphism (RFLP) analysis,
RNA inhibition analysis, and single nucleotide polymor-
phism (SNP) analysis with significant overlap among
them to support one another. These developments have
set the stage for excellent growth potential in the market-
place. Histopathology, an approximately 1 billion market
worldwide is growing at 10% per annum [17] despite the
fact that molecular diagnostic's contribution to such sta-
tistics is only a minuscule. Further down the century, his-
topathology, molecular biology and IT sector combinedPublish with BioMed Central    and   every 
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will make the modern Histopathologist's market enjoy a
good share in the healthcare sector. Is the fresh entrant
into pathology training aware of this growing aspect of
healthcare?
Conclusion
So, are we looking at a histopathologist, who is not only a
good traditional morphologist, but also an IT savvy scien-
tist, with drops of Leonardo Da Vinci and Picasso in
blood, who is ready to take technology head-on, without
the inhibitions the current generation of pathologists face
and who would look at the histopathology market with a
much wider perspective of the current economy? The
making of this Modern Histopathologist would require a
drastic change in the accreditation procedure and a major
initiative on the part of the policy makers and the teachers
of Pathology. The transition from a field of visual interpre-
tations to a largely invisible molecular science will take
some time to firm foot but will eventually be there.
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